MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q3
hinzugefügt 14.11.2023
Atreca ROCE 2011-2026 | BCEL
ROCE Jährlich Atreca
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -34.9 | -38.65 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -34.9 | -38.65 | -36.78 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
167.74 | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
-25.04 | - | 4.01 % | $ 150 M |  Canada |
 |
MorphoSys AG
MOR
|
2.89 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
-23.06 | - | 1052.0 % | $ 415 M | USA |
 |
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | USA |
 |
Adagene
ADAG
|
-46.22 | $ 2.81 | -3.61 % | $ 158 M |  China |
 |
Biogen
BIIB
|
31.45 | $ 176.6 | 0.24 % | $ 25.7 B | USA |
 |
BioNTech SE
BNTX
|
-4.81 | $ 114.69 | -1.78 % | $ 27.2 B | Germany |
 |
ANI Pharmaceuticals
ANIP
|
0.14 | $ 80.99 | -1.23 % | $ 1.56 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | USA |
 |
Amgen
AMGN
|
123.5 | $ 340.73 | -0.64 % | $ 183 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-40.28 | - | - | $ 1.01 B | USA |
 |
Biophytis SA
BPTS
|
-325.06 | - | -13.47 % | $ 169 M |  France |
 |
Burford Capital Limited
BUR
|
14.24 | $ 9.61 | -0.47 % | $ 1.53 B |  Britain |
 |
Midatech Pharma plc
MTP
|
-337.43 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | USA |
 |
Aytu BioScience
AYTU
|
-12.81 | $ 2.59 | 0.39 % | $ 16.3 M | USA |
 |
CASI Pharmaceuticals
CASI
|
-49.51 | $ 0.99 | -0.01 % | $ 135 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-104.38 | $ 3.25 | -0.35 % | $ 7.82 B |  Australia |
 |
Akero Therapeutics
AKRO
|
-38.05 | - | - | $ 3.67 B | USA |
 |
Catalyst Biosciences
CBIO
|
424.75 | $ 9.72 | -4.19 % | $ 640 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
-252.54 | - | 3.16 % | $ 1.9 M | USA |
 |
AVROBIO
AVRO
|
10.76 | - | 1083.1 % | $ 745 M | USA |
 |
Cerus Corporation
CERS
|
-25.34 | $ 2.25 | -3.02 % | $ 415 M | USA |
 |
Aptose Biosciences
APTO
|
-46.69 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aravive
ARAV
|
-664.7 | - | -13.39 % | $ 1.45 M | USA |
 |
Cellectis S.A.
CLLS
|
-20.47 | $ 3.91 | -2.03 % | $ 116 M | France |
 |
Brickell Biotech
BBI
|
-64.05 | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Molecular Transport
AMTI
|
-209.11 | - | - | $ 10.1 M | USA |
 |
Beam Therapeutics
BEAM
|
-56.65 | $ 28.22 | -3.65 % | $ 2.32 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
-45.89 | $ 223.02 | -0.42 % | $ 5 B |  Danmark |
 |
Athira Pharma
ATHA
|
-225.02 | - | - | $ 269 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
26.82 | $ 24.39 | -0.77 % | $ 2.89 B | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
8.53 | $ 68.44 | -0.98 % | $ 9.15 B | USA |
 |
Cardiff Oncology
CRDF
|
-58.65 | $ 1.69 | 4.77 % | $ 80.5 M | USA |
 |
Aeterna Zentaris
AEZS
|
-29.95 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-180.78 | - | -10.17 % | $ 12.2 K | USA |
 |
Akouos
AKUS
|
-37.16 | - | 0.23 % | $ 488 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-1339.01 | - | -9.72 % | $ 5.89 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-353.66 | - | -15.15 % | $ 60.3 M | Britain |
 |
Berkeley Lights
BLI
|
-69.03 | - | -7.31 % | $ 87 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-115.03 | $ 4.04 | -1.5 % | $ 8.79 B |  Israel |
 |
Amneal Pharmaceuticals
AMRX
|
10.81 | $ 13.91 | -1.45 % | $ 4.3 B | USA |
 |
AIkido Pharma
AIKI
|
-28.92 | - | 1.93 % | $ 17.4 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
-883.35 | - | -74.18 % | $ 955 K | USA |
 |
CureVac N.V.
CVAC
|
-51.5 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
146.85 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-32.41 | - | - | $ 2.17 B | USA |